Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial
20 May 2023 (08:00 - 20:00)
Organised by: 
About the speaker
Nagoya University Graduate School of Medicine, Nagoya (Japan)
4 More presentations in this session
Doctor S. Matsumoto (Tokyo, JP)
Ms C. Oliveira (Porto, PT)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
You may be interested in
Congress Presentation
Congress Presentation
